Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abandonment, Accredo, adapt, affirmative, AG, age, alcohol, Aliz, allegedly, amino, aminoglycoside, Amneal, antibiotic, antibody, anticompetitive, appellate, ASP, asparaginase, Asparec, aspect, assay, ASU, ATRA, attend, audience, auditor, austerity, bacterium, BCA, Big, biosimilar, Biotest, BLA, blend, block, BPCIA, breakdown, breakout, breakthrough, breathing, bribery, British, brochure, burden, Burlington, Caphosol, capped, capromab, carbidopa, cardiovascular, Castle, casualty, catherine, cessation, chain, chargeback, cheaper, chemotherapy, childhood, chorea, chronotherapeutic, chrysanthemi, Circ, Citizen, clarified, CND, Coast, CODM, coli, collagen, Collatamp, compassionate, compel, compelling, condemnation, confidence, Connaught, constitutionality, construing, contamination, contractor, contraindication, Convention, conversion, core, Corrupt, Cove, creation, crucial, CSA, cure, currency, Custodiol, de, decentralized, declaratory, deploy, deployment, deprive, deprived, depriving, developmental, devise, digestive, discovered, distract, diversification, divested, divestiture, division, Durbin, dynamically, efficient, efficiently, eleven, environment, enzyme, Erwinase, Erwinaze, Erwinia, Escherichia, Essex, ETASU, ethylene, EU, Eurozone, EUSA, evidenced, evolving, exceptionally, excise, fact, falsified, fashion, FCP, FCPA, feasible, fifty, finite, Fintan, floor, footprint, forecast, forecasted, formation, formatting, France, French, FSS, FTC, fungal, FY, GBP, gentamicin, Germany, glycol, graft, grown, guarantor, Guard, headquartered, heard, heavily, heightened, Hooper, host, house, HPA, HRSA, HTK, Huntington, hypercholesterolaemia, hypersensitive, hypersensitivity, hypnogogic, hypothermic, imaging, immunologically, impregnated, improperly, impurity, indefinitely, inferred, infrastructure, injured, inolimomab, insert, insolvency, instability, internationally, intervention, intramuscular, Iranian, Japan, Jewel, John, justify, Keegan, kidney, Kidrolase, Kingdom, KPMG, Langhorne, legacy, lending, lengthened, Leukaemic, leukemia, leukemic, Leukotac, levodopa, lexidronam, liaison, LIBOR, lifecycle, lifted, liver, lump, lymphoblastic, lymphoma, Lyon, lyophilized, maker, mandatory, manifesting, Mayflower, Meda, MEPH, Mexico, microbially, Ministry, misleading, mission, mix, monoclonal, Morton, movement, NAVIGATOR, official, OPi, outbreak, outreach, outweigh, overcharge, overhead, oversee, Oxford, paediatric, passage, PCAOB, pegylated, penalized, pendetide, petition, pH, pharmacovigilance, phosphate, pilot, pipeline, platform, poisoning, pose, postural, Pound, poverty, pre, privacy, procedure, ProgramTM, promising, ProstaScint, prostate, prudent, psychology, Psychotropic, Pub, Quadramet, radiation, radiopharmaceutical, raw, reaction, ready, reallocate, recipient, recombinant, redeem, redeemable, reexamination, refilled, remeasured, repricing, reschedule, rescheduled, rescind, respiratory, rest, retrospective, revoked, rinse, rinsing, Road, Ronan, route, routinely, salary, samarium, SAS, Sawochka, segregated, sensitivity, sequestration, shaped, signatory, silent, sm, snail, Society, sohn, sovereign, speak, speech, statutorily, strain, stricter, strictly, struck, sublease, subsection, Sunshine, supersaturated, Supreme, Surrender, survey, Suzanne, swing, switching, talented, taxation, tentative, tetrabenazine, Threat, timeframe, TMA, Topic, traced, Tramadol, transformational, translate, translated, translation, transpire, transplantation, trillion, truthful, UK, uncovered, underway, undistributed, unfavorable, unremitted, upper, USPTO, VA, vacate, Versacloz, VersaclozTM, VHCA, viability, violative, vision, vital, vitro, vivo, winding, workforce, worth, Xenazine
Removed:
alan, alternate, analyzing, announced, asserted, BB, bore, Cephalon, certificate, children, clarification, commencement, commercialized, complicated, comprise, compromise, concomitant, confirmed, consumed, contact, contacting, cressey, depressive, detention, documented, entail, escalation, establishment, evaluated, exacerbation, exercisable, forced, harmful, improved, inception, incremental, informed, inspect, invoiced, JPI, judicially, led, Lonza, minimal, moderate, modification, partner, pattern, pivotal, Porter, preferable, qualification, recognizable, reject, reliably, removed, renewable, Revision, robert, sebulsky, separable, stimulant, structured, subcommittee, theInternational, tracked, undelivered, withdraw
Filing tables
Filing exhibits
- 10-K Annual report
- 10.13 Surrender of Lease
- 10.27 Us Rsu Notice & Agreement - 2007 Eip
- 10.28 Non-us Option Notice & Agreement - 2011 Eip
- 10.27 Us Option Notice & Agreement - 2007 Eip
- 10.27 Irish Option Notice & Agreement - 2007 Eip
- 10.27 Irish Rsu Notice & Agreement - 2007 Eip
- 10.28 Non-us Rsu Notice & Agreement - 2011 Eip
- 10.30 Non-us Option Notice & Agreement - 2007 Nesop
- 10.31 2007 Employee Stock Purchase Plan
- 10.32 Cash Bonus Plan - Us Affiliates
- 10.32 Cash Bonus Plan - International Affiliates 2003
- 21.1 Subsidiaries
- 23.1 Consent of KPMG, Independent Registered Public Accounting Firm
- 23.2 Consent of Ernst & Young, LLP, Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 31.2 Certification of CFO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certifications of CEO and CFO Pursuant to 18 U.s.c. Section 1350
Related press release
JAZZ similar filings
Filing view
External links
Exhibit 23.2
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-179075) pertaining to the 2011 Equity Incentive Plan, the 2007 Equity Incentive Plan, the 2003 Equity Incentive Plan, the 2007 Employee Stock Purchase Plan, the Amended and Restated 2007 Non-Employee Directors Stock Option Plan and the Amended and Restated Directors Deferred Compensation Plan of Jazz Pharmaceuticals plc (the Successor), and the Registration Statement (Form S-3 No. 333-179080) of Jazz Pharmaceuticals plc and in the related prospectuses, of our report dated February 28, 2012, with respect to the consolidated balance sheet of Jazz Pharmaceuticals, Inc. (the Predecessor) and its subsidiaries as of December 31, 2011, the related consolidated statements of income, comprehensive income, stockholders' equity (deficit), and cash flows for each of the two years in the period ended December 31, 2011, and the related financial statement schedule for 2011 and 2010, included in this Annual Report (Form 10-K) for the year ended December 31, 2012.
/s/ Ernst & Young LLP
Redwood City, California
February 26, 2013